The dual kinase complex FAK-Src as a promising therapeutic target in cancer

References

• GuoWGiacontiFGIntegrin signaling during tumor progressionNat Rev Mol Cell Biol200451081682615459662
   PubMed Web of Science ®Google Scholar
• CalalbMBPolteTRHanksSKTyrosine of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinasesMol Cell Biol1995159549637529876
   PubMed Web of Science ®Google Scholar
• MitraSatyajit KSchlaepferDavid DIntegrin-regulated FAK–Src signaling in normal and cancer cellsCurrent Opinion in Cell Biology200618551652316919435
   PubMed Web of Science ®Google Scholar
• BrutonVGMacPhersonIRJFrameMCCell adhesion receptors, tyrosine kinases and actin modulators: a complex three-way circuitryBiochim Biophys Acta2004169212114415246683
   PubMed Web of Science ®Google Scholar
• PlayfordMPSchallerMDThe interplay between Src and integrins in normal and tumor biologyOncogene20041823487928794615489911
   PubMed Web of Science ®Google Scholar
• WangSEXiangBZentRQuarantaVPozziAArteagaCLTransforming growth factor beta induces clustering of HER2 and integrins by activating Src-focal adhesion kinase and receptor association to the cytoskeletonCancer Res200969247547819147560
   PubMed Web of Science ®Google Scholar
• BromannPAKorkayaHCourtneidgeSAThe interplay between Src family kinases and receptor tyrosine kinasesOncogene200423487957796815489913
   PubMed Web of Science ®Google Scholar
• ChiangACMassaguéJMolecular basis of metastasisN Engl J Med2008359262814282319109576
   PubMed Web of Science ®Google Scholar
• Van NimwegenMJVan DewaterBFocal adhesion kinase: a potential target in cancer therapyBiochem Pharmacol20077359760916997283
   PubMed Web of Science ®Google Scholar
• MorganLNicholsonRIHiscoxSSRC as a therapeutic target in breast cancerEndocr Metab Immune Disord Drug Targets20088427327819075780
   PubMedGoogle Scholar
• ParsonsJTSlack-DavisJTilghmanRRobertsWGFocal adhesion kinase: targeting adhesion signaling pathways for therapeutic interventionClin Cancer Res200814362763218245520
   PubMed Web of Science ®Google Scholar
• FinnRSTargeting Src in breast cancerAnn Oncol20081981379138618487549
   PubMed Web of Science ®Google Scholar
• Slack-DavisJKMartinKHTilghmanRWIwanickiMCellular characterization of a novel focal adhesion kinase inhibitorJ Biological Chem2007282201484514852
   PubMed Web of Science ®Google Scholar
• JarkowskiASweeneyRPNilotinib: a new tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemiaPharmacotherapy200828111374138218956997
   PubMed Web of Science ®Google Scholar
• SiuLLPhase 1 study of a focal adhesion kinase (FAK) inhibitor PF-00562271 in patients (pts) with advanced solid tumorsAbstract 35272007 ASCO Annual MeetingChicago, IL, USA
   Google Scholar
• SiuLLA phase I clinical, pharmacokinetic (PK) and pharmacodynamic (PD) evaluation of PF-00562271 targeting focal adhesion kinase (FAK) in patients (pts) with advanced solid tumorsAbstract 35342008 ASCO Annual MeetingChicago, IL, USA
   Google Scholar
• AraujoJArmstrongAJBraudELDasatinib and docetaxel combination treatment for patients with castration-resistant progressive prostate cancer: A phase I/II study (CA180086)Abstract 50612009 ASCO Annual MeetingChicago, IL, USA
   Google Scholar
• KlugerHMDudekAMcCannCA phase II trial of dasatinib inadvanced melanomaAbstract 90102009 ASCO Annual MeetingChicago, IL, USA
   Google Scholar
• MayerEBaurainJSparanoJDasatinib in advanced HER2/neu amplified and ER/PR-positive breast cancer: Phase II study CA180088Abstract 10112009 ASCO Annual MeetingChicago, IL, USA
   Google Scholar
• RousPATransmission of a malignant new growth by means of a cell-free filtrateJAMA191156198202
   Google Scholar
• RousPAA sarcoma of the fowl transmissible by an agent separable from the tumor cellsJ Exp Med191113439741119867421
   PubMedGoogle Scholar
• Steven MartinGThe hunting of the SrcNature Rev Molec Cell Biol2001246747511389470
   PubMed Web of Science ®Google Scholar
• YeatmanTJA renaissance for SRCNat Rev Cancer20044647048015170449
   PubMed Web of Science ®Google Scholar
• IngleyESrc family kinases: regulation of their activities, levels and identification of new pathwaysBiochim Biophys Acta200817841566517905674
   PubMed Web of Science ®Google Scholar
• CoxBDNatarajanMStettnerMRGladsonCLNew concepts regarding focal adhesion kinase promotion of cell migration and proliferationJ Cell Biochem2006991355216823799
   PubMed Web of Science ®Google Scholar
• KannerSBMonoclonal antibodies to individual tyrosine-phosphorylated protein substrates of oncogene-encoded tyrosine kinasesProc Natl Acad Sci1990879332833322110361
   PubMed Web of Science ®Google Scholar
• ShallerMDBorgmanCACobbBSpp125FAK a structurally distinctive protein-tyrosine kinase associated with focal adhesionsProc Natl Acad Sci199289519251961594631
   PubMed Web of Science ®Google Scholar
• SchallerMDParsonsJTFocal adhesion kinase and associated proteinsCurr Opin Cell Biol199467057717833050
   PubMed Web of Science ®Google Scholar
• BruntonVGAvizienyteEFinchamVJIdentification of Src-specific phosphorylation site on focal adhesion kinase: dissection of the role of Src SH2 and catalytic functions and their consequences for tumor cell behaviorCancer Res20056541335134215735019
   PubMed Web of Science ®Google Scholar
• AvizienyteEWykeAWJonesRJSrc-induced de-regulation of E-cadherin in colon cancer cells requires integrin signalingNat Cell Biol20024863263812134161
   PubMed Web of Science ®Google Scholar
• SiegDJHauckCRIlicDFAK integrates growth-factor and integrin signals to promote cell migrationNat Cell Biol20002524925610806474
   PubMed Web of Science ®Google Scholar
• EliceiriBPPuenteXSHoodJDSrc-mediated coupling of focal adhesion kinase to integrin alpha(v)beta5 in vascular endothelial growth factor signalingJ Cell Biol2002157114916011927607
   PubMed Web of Science ®Google Scholar
• SchallerMDBorgmanCAParsonsJTAutonomous expression of a noncatalytic domain of the focal adhesion associated protein tyrosine kinase pp.125FAKMol Cell Biol1993137857918423801
   PubMed Web of Science ®Google Scholar
• MitraSKSchaepferDDIntegrin-regulated FAK-C-src signaling in normal and cancer cellsCurr Opin Cell Biol20061851652316919435
   PubMed Web of Science ®Google Scholar
• ZhaoJGuanJLSignal transduction by focal adhesion kinase in cancerCancer Metastasis Rev2009281–2354919169797
   PubMed Web of Science ®Google Scholar
• ParsonsJTMartinKHSlackJKTaylorJMFocal adhesion kinase: a regulator of focal adhesion dynamics and cell movementOncogene200019495606561311114741
   PubMed Web of Science ®Google Scholar
• SummyJMGallickGESrc family kinases in tumor progression and metastasisCancer Metastasis Rev20032233735812884910
   PubMed Web of Science ®Google Scholar
• IlicDFurutaYKanazawaSReduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient miceNature19953775395447566154
   PubMed Web of Science ®Google Scholar
• PengXUedaHZhouHOverexpression of focal adhesion kinase in vascular endothelial cells promotes angiogenesis in transgenic miceCardiovascular Res200464421430
   PubMed Web of Science ®Google Scholar
• WeisSMLimSTLutu-FugaKMCompensatory role for Pyk2 during angiogenesis in adult mice lacking endothelial cell. FAKJ Cell Biol2008181435018391070
   PubMed Web of Science ®Google Scholar
• GuinamardROkigakiMSchlessingerJRavetichJVAbsence of marginal zone B cell in Pyk2-deficient mice defines their role in the humoral responseNat Immunol20001313610881171
   PubMed Web of Science ®Google Scholar
• OkigakiMDavisCFalascaMPyk2 regulates multiple signaling events crucial for macrophage morphology and migrationProc Nat Acad Sci2003100107401074512960403
   PubMed Web of Science ®Google Scholar
• LimSTChenXLLimYNuclear FAK promotes cell proliferation and survival through FERM-enhanced p53 degradationMol Cell200829192218206965
   PubMed Web of Science ®Google Scholar
• SorianoPMontgomeryCGeskeRBradleyATargeted disruption of the c-src proto-oncogene leads to osteopetrosis in miceCell19916446937021997203
   PubMed Web of Science ®Google Scholar
• RoodmanGDMechanisms of bone metastasisN Engl J Med20043501655166415084698
   PubMed Web of Science ®Google Scholar
• RucciNTetiSusa MInhibition of protein kinase c-Src as a therapeutic approach for cancer and bone metastasesAnticancer Agents Med Chem20088334234918393792
   PubMed Web of Science ®Google Scholar
• ZhanMZhaoHHanZCSignaling mechanisms of anoikisHistol Histopathol200419397398315168359
   PubMed Web of Science ®Google Scholar
• DuxburyMSItoHZinnerMJAshleySWWhangEEFocal adhesion kinase gene silencing promotes anoikis and suppresses metastasis of human pancreatic adenocarcinoma cellsSurgery2004135555556215118593
   PubMed Web of Science ®Google Scholar
• LiuGMengXJinYInhibitory role of focal adhesion kinase on anoikis in the lung cancer cell A549Cell Biol Int200832666367018343694
   PubMed Web of Science ®Google Scholar
• Díaz-MonteroCMWygantJNMcIntyreBWPI3-K/Akt-mediated anoikis resistance of human osteosarcoma cells requires Src activationEur J Cancer20064210149150016759849
   PubMed Web of Science ®Google Scholar
• Gabarra-NieckoVSchallerMDDuntyJMFAK regulates biological processes important for the pathogenesis of cancerCancer Metastasis Rev200322435937412884911
   PubMed Web of Science ®Google Scholar
• Grisaru-GranovskySSalahZMaozMPrussDBellerUBar-ShavitRDifferential expression of protease activated receptor 1 (Par1) and pY397FAK in benign and malignant human ovarian tissue samplesInt J Cancer2005113337237815455382
   PubMed Web of Science ®Google Scholar
• RecherCYsebaertLBeyne-RauzyOExpression of focal adhesion kinase in acute myeloid leukemia is associated with enhanced blast migration, increased cellularity, and poor prognosisCancer Res20046493191319715126359
   PubMed Web of Science ®Google Scholar
• AronsohnMSBrownHMHauptmanGKornbergLJ Expression of focal adhesion kinase and phosphorylated focal adhesion kinase in squamous cell carcinoma of the larynx. Aronsohn MS, Brown HM, Hauptman G, Kornberg LJ.
   Google Scholar
• MoonHSParkWIChoiEAChungHWKimSCThe expression and tyrosine phosphorylation of E-cadherin/catenin adhesion complex, and focal adhesion kinase in invasive cervical carcinomasInt J Gynecol Cancer200313564064614675348
   PubMed Web of Science ®Google Scholar
• DingJLiDWangXWangCWuTFibronectin promotes invasiveness and focal adhesion kinase tyrosine phosphorylation of human colon cancer cellHepatogastroenterology200855882072207619260479
   PubMedGoogle Scholar
• PantaGRNwariakuFKimLTRET signals through focal adhesion kinase in medullary thyroid cancer cellsSurgery200413661212121715657578
   PubMed Web of Science ®Google Scholar
• PantaGRDuLNwariakuFEKimLTDirect phosphorylation of proliferative and survival pathway proteins by RETSurgery2005138226927416153436
   PubMed Web of Science ®Google Scholar
• TongZKunnumakkaraABWangHNeutrophil gelatinase-associated lipocalin: a novel suppressor of invasion and angiogenesis in pancreatic cancerS Cancer Res2008681561006108
   Web of Science ®Google Scholar
• LiuTJLaFortuneTHondaTInhibition of both focal adhesion kinase and insulin-like growth factor-I receptor kinase suppresses glioma proliferation in vitro and in vivoMol Cancer Ther2007641357136717431114
   PubMed Web of Science ®Google Scholar
• SchweppeREKeregeAAFrenchJDSharmaVGrzywaRLHaugenBRInhibition of Src with AZD0530 reveals the Src-Focal Adhesion kinase complex as a novel therapeutic target in papillary and anaplastic thyroid cancerJ Clin Endocrinol Metab20099462199220319293266
   PubMed Web of Science ®Google Scholar
• ChenJIs Src the key to understanding metastasis and developing new treatments for colon cancer?Nat Clin Pract Gastroenterol Hepatol20085630630718477987
   PubMedGoogle Scholar
• HaskellHNatarajanMHeckerTPFocal adhesion kinase is expressed in the angiogenic blood vessels of malignant astrocytic tumors in vivo and promotes capillary tube formation of brain microvascular endothelial cellsClin Cancer Res2003962157216512796381
   PubMed Web of Science ®Google Scholar
• AngelucciABolognaMCurr. Targeting vascular cell migration as a strategy for blocking angiogenesis: the central role of focal adhesion protein tyrosine kinase familyPharm Des2007132121292145
   Google Scholar
• EarleySPlopperEDisruption of focal adhesion kinase slows transendothelial migration of AU-565 breast cancer cellsBiochem Biophys Res Commun200635040541217010315
   PubMed Web of Science ®Google Scholar
• EliceiriBPPaulRSchwartzbergPLHoodJDLengJChereshDASelective requirement for C-src kinases during VEGF-induced angiogenesis and vascular permeabilityMol Cell1999491592410635317
   PubMed Web of Science ®Google Scholar
• NiuGConstitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesisOncogene2002212000200811960372
   PubMed Web of Science ®Google Scholar
• KilarskiWWJuraNGerwinsPInactivation of Src family kinases inhibits angiogenesis in vivo: implications for a mechanism involving organization of the actin cytoskeletonExp Cell Res2003291708214597409
   PubMed Web of Science ®Google Scholar
• LairdADSrc family kinase activity is required for signal tranducer and activator of transcription 3 and focal adhesion kinase phosphorylation and vascular endothelial growth factor signaling in vivo and for anchorage-dependent and-independent growth of human tumor cellsMol Cancer Ther2003246146912748308
   PubMed Web of Science ®Google Scholar
• ShetaEAHardingMAConawayMRTheodorescuDFocal adhesion kinase, Rap1, and transcriptional induction of vascular endothelial growth FactorJ Natl Cancer Inst200092131065107310880549
   PubMedGoogle Scholar
• CasconeINapioneLManieroFSeriniGBussolinoFJStable interaction between alpha5beta1 integrin and Tie2 tyrosine kinase receptor regulates endothelial cell response to Ang-1Cell Biol200517069931004
   Web of Science ®Google Scholar
• HalderJLandenCNJrLutgendorfSKFocal adhesion kinase silencing augments docetaxel-mediated apoptosis in ovarian cancer cellsClin Cancer Res20051124 Pt 18829883616361572
   PubMed Web of Science ®Google Scholar
• DuxburyMSItoHBenoitEZinnerMJAshleySWWhangEERNA interference targeting focal adhesion kinase enhances pancreatic adenocarcinoma gemcitabine chemosensitivityBiochem Biophys Res Commun2003311378679214623342
   PubMed Web of Science ®Google Scholar
• IschenkoICamajPSeeligerHInhibition of Src tyrosine kinase reverts chemoresistance toward 5-fluorouracil in human pancreatic carcinoma cells: an involvement of epidermal growth factor receptor signalingOncogene200827577212722218794807
   PubMed Web of Science ®Google Scholar
• DuxburyMSItoHZinnerMJAshleySWWhangEEInhibition of SRC tyrosine kinase impairs inherent and acquired gemcitabine resistance in human pancreatic adenocarcinoma cellsClin Cancer Res20041072307231815073106
   PubMed Web of Science ®Google Scholar
• DuxburyMSItoHZinnerMJAshleySWWhangEEsiRNA directed against c-Src enhances pancreatic adenocarcinoma cell gemcitabine chemosensitivityJ Am Coll Surg2004198695395915194078
   PubMed Web of Science ®Google Scholar
• ShahANGallickGESrc, chemoresistance and epithelial to mesenchymal transition: are they related?Anticancer Drugs200718437137517351389
   PubMed Web of Science ®Google Scholar
• MayerEBaurainJSparanoJDasatinib in advanced HER2/neu amplified and ER/PR-positive breast cancer: Phase II study CA180088Abstract: 10112009 ASCO Annual MeetingChicago IL, USA
   Google Scholar
• GutenbergABrückWBuchfelderMLudwigHCExpression of tyrosine kinases FAK and Pyk2 in 331 human astrocytomasActa Neuropathol2004108322423015221336
   PubMed Web of Science ®Google Scholar
• BehmoaramEBijianKJieSFocal adhesion kinase-related proline-rich tyrosine kinase 2 and focal adhesion kinase are co-overexpressed in early-stage and invasive ErbB-2-positive breast cancer and cooperate for breast cancer cell tumorigenesis and invasivenessAm J Pathol200817351540155018832579
   PubMed Web of Science ®Google Scholar
• SunCKNgKTSunBSThe significance of proline-rich tyrosine kinase2 (Pyk2) on hepatocellular carcinoma progression and recurrenceBr J Cancer2007971505717551499
   PubMed Web of Science ®Google Scholar
• IiizumiMBandyopadhyaySPaiSKRhoC promotes metastasis via activation of the Pyk2 pathway in prostate cancerCancer Res200868187613762018794150
   PubMed Web of Science ®Google Scholar
• ZhangSQiuXGuYWangEUp-regulation of proline-rich tyrosine kinase 2 in non-small cell lung cancerLung Cancer200862329530118571765
   PubMed Web of Science ®Google Scholar
• JohnsonFMGallickGESRC family nonreceptor tyrosine kinases as molecular targets for cancer therapyAnticancer Agents Med Chem20077665165918045060
   PubMed Web of Science ®Google Scholar
• ThieryJPEpithelial-mesenchymal transitions in development and pathologiesCurr Opin Cell Biol200315674074614644200
   PubMed Web of Science ®Google Scholar
• PeinadoHOlmedaDCanoASnail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?Nat Rev Cancer20077641542817508028
   PubMed Web of Science ®Google Scholar
• SabbahMEmamiSRedeuilhGMolecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancersDrug Resist Updat2008114–512315118718806
   PubMed Web of Science ®Google Scholar
• BaileyKMLiuJJCaveolin-1 up-regulation during epithelial to mesenchymal transition is mediated by focal adhesion kinaseBiol Chem2008283201371413724
   Web of Science ®Google Scholar
• CicchiniCLaudadioICitarellaFTGFbeta-induced EMT requires focal adhesion kinase (FAK) signalingExp Cell Res2008314114315217949712
   PubMed Web of Science ®Google Scholar
• MandalMMyersJNLippmanSMEpithelial to mesenchymal transition in head and neck squamous carcinoma: association of Src activation with E-cadherin down-regulation, vimentin expression, and aggressive tumor featuresCancer200811292088210018327819
   PubMed Web of Science ®Google Scholar
• WeiJXuGWuMOverexpression of vimentin contributes to prostate cancer invasion and metastasis via src regulationAnticancer Res2008281A32733418383865
   PubMed Web of Science ®Google Scholar
• LombardoLJLeeFYChenPDiscovery of N-(2-chloro-6methylphneyl)-2-(6-(4-(2-hydroxyethyl)-piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5 carboxamide (BMS-354825),a dual Src/Abl. kinase inhibitor with potent antitumor activityin pre-clinical assaysJ Med Chem200447276658666115615512
   PubMed Web of Science ®Google Scholar
• TokarskiJSNewittJAChangCYThe structure of Dasatinib (BMS-354825) bound to activated ABL kinase domain elucidates its inhibitory activity against imatinib-resistant ABL mutantsCancer Res2006 1;66115790579716740718
   PubMed Web of Science ®Google Scholar
• KopetzSShahANGallickGESrc continues aging: current and future clinical directionsClin Cancer Res200713247232723618094400
   PubMed Web of Science ®Google Scholar
• FinnRSDeringJGintherCDasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/“triple-negative” breast cancer cell lines growing in vitroBreast Cancer Res Treat2007105331932617268817
   PubMed Web of Science ®Google Scholar
• HuangFReevesKHanXIdentification of candidate molecular markers predicting sensitivity in solid tumors to dasatinib: rationale for patient selectionCancer Res20076752226223817332353
   PubMed Web of Science ®Google Scholar
• ParkSIZhangJPhillipsKATargeting SRC family kinases inhibits growth and lymph node metastases of prostate cancer in an orthotopic nude mouse modeCancer Res20086893323333318451159
   PubMed Web of Science ®Google Scholar
• LeXiao-FengMaoWeiqunLuZhenBastRobert CJrDasatinib induces autophagy as well as growth arrest in human ovarian cancer cellsAbstract 388 AACR 2009
   Google Scholar
• TryfonopoulosDO’DonovanNCorkeryBClynesMCrownJActivity of dasatinib with chemotherapy in triple-negative breast cancer cellsAbstract: e146052009 ASCO Annual MeetingChicago, IL, USA
   Google Scholar
• SeoaneSMonteroJCPandiellaAOcanaAEffect of dasatinib on the activity of trastuzumab in HER2- overexpressing breast cancer cellsAbstract: 10842009 ASCO Annual MeetingChicago, IL, USA
   Google Scholar
• HennequinLFAllenJBreedJN-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-(tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine, a novel, highly selective, orally available, dual-specific c-Src/Abl kinase inhibitorMed Chem2006492264656488
   Web of Science ®Google Scholar
• HiscoxSMorganLGreenTPBarrowDGeeJNicholsonRIElevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cellsBreast Cancer Res Treat20069726327416333527
   PubMed Web of Science ®Google Scholar
• HiscoxSJordanNJSmithCDual targeting of Src and ER prevent acquired antihormone resistance in breast cellsBreast Cancer Res Treat20091151576718493848
   PubMed Web of Science ®Google Scholar
• ChenYGuggisbergNJordaMCombined Src and Aromatase Inhibition Impairs Human Breast Cancer Growth In vivo and Bypass Pathways Are Activated in AZD0530-Resistant TumorsClin Cancer Res200915103396340519451593
   PubMed Web of Science ®Google Scholar
• HerynkMHBeyerARCuiYCooperative action of tamoxifen and c-Src inhibition in preventing the growth of estrogen receptor-positive human breast cancer cellsMol Cancer Ther20065123023303117172405
   PubMed Web of Science ®Google Scholar
• Clinical Trials.gov Clinical Trials AZDO530 at: http://www.clinicaltrial.gov/ct2/results?term=AZD0530+ accessed March 2010.
   Google Scholar
• StratfordIJTelferBGreenTPInhibition of metastatic dissemination following loco-regional control of a primary tumor: examining a novel treatment paradigm with the Src kinase inhibitor AZD0530Abstract 4946 AACR 2009
   Google Scholar
• BoschelliDHWuBYeFSynthesis and Src kinase inhibitory activity of a series of 4-[(2,4-dichloro-5-methoxyphenyl)amino]-7-furyl-3-quinolinecarbonitrilesJ Med Chem200649267868787617181170
   PubMed Web of Science ®Google Scholar
• RabbaniSAValentinoMLAliSBoschelliFInhibitor of Src kinase SKI-606 (Bosutinb) blocks prostate cancer growth, invasion and experimental skeletal metastases in vitro and in vivo by regulating the expression of key intracellular signaling molecules and genes involved in prostate cancer progressionAbstract 2325 AACR 2009
   Google Scholar
• JallalHValentinoMLChenGBoschelliFAliSRabbaniSAA Src/Abl kinase inhibitor, SKI-606, blocks breast cancer invasion, growth, and metastasis in vitro and in vivoCancer Res20076741580158817308097
   PubMed Web of Science ®Google Scholar
• MessersmithWAKrishnamurthiSHewesBABosutinib (SKI-606), a dual Src/Abl tyrosine kinase inhibitor: Preliminary results from a phase 1 study in patients with advanced malignant solid tumorsAbstract 35522007 ASCO Annual MeetingChicago, IL, USA
   Google Scholar
• Clinical Trials.gov Clinical Trials Bosutinib at: http://www.clinicaltrial.gov/ct2/results?term=Bosutinib+ accessed March 2010.
   Google Scholar
• RobertsWGUngEWhalenPAntitumor Activity and Pharmacology of a Selective Focal Adhesion Kinase Inhibitor, PF-562,271Cancer Res20086861935194418339875
   PubMed Web of Science ®Google Scholar
• JaymeBStokesSJAdairJKTargeting FAK in pancreatic cancer: a novel therapeutic approachAbstract 843, AACR 2209
   Google Scholar
• BagiCMChristensenJCohenDPSunitinib and PF-562,271 (FAK/Pyk2 inhibitor) effectively block growth and recovery of human hepatocellular carcinoma in a rat xenograft modelCancer Biology and Therapy20098985686519458500
   PubMed Web of Science ®Google Scholar
• CasconeINapioneLManieroFSeriniGBussolinoFJStable interaction between alpha5beta1 integrin and Tie2 tyrosine kinase receptor regulates endothelial cell response to Ang-1Cell Biol200517069931004
   Web of Science ®Google Scholar
• BagiCMRobertsGWAndresenCJDual focal adhesion kinase/Pyk2 inhibitor has positive effects on bone tumors: implications for bone metastasesCancer2008112102313232118348298
   PubMed Web of Science ®Google Scholar
• Slack-DavisJKMartinKHTilghmanRWCellular characterization of a novel focal adhesion kinase inhibitorJ Biol Chem200728220148451485217395594
   PubMed Web of Science ®Google Scholar
• StoneRLNickAMSpannuthWThe clinical and biological significance of focal adhesion kinase activation in ovarian carcinomaAbstract 3636 AACR 2009
   Google Scholar
• Dos SantosLAThe FAK Inhibitor PF573228 Demonstrates Anti-proliferative and anti-invasive activity in MUC16/CA125 ovarian carcinoma cellsAbstract 3519 AACR 2009
   Google Scholar
• HalderJLinYGMerrittWMTherapeutic efficacy of a novel focal adhesion kinase inhibitor TAE226 in ovarian carcinomaCancer Res20076722109761098318006843
   PubMed Web of Science ®Google Scholar
• LiuWBloomDACanceWGKurenovaEVGolubovskayaVMHochwaldSNFAK and IGF-IR interact to provide survival signals in human pancreatic adenocarcinoma cellsCarcinogenesis20082961096110718263593
   PubMed Web of Science ®Google Scholar
• HaoHWangZBaoXDual tyrosine kinase inhibitor for focal adhesion kinase and insulin-like growth factor-I receptor (TAE226) leads to apoptosis in esophageal cancer by inhibiting AKT-mTOR survival signalingAbstract 1840 AACR 2009
   Google Scholar
• UcarDKurenovaEZhengDA novel small molecule that targets the FAK and IGF-1R site of interaction inhibits growth of human cancerAbstract 2008 AACR 2009
   Google Scholar
• VilledieuMDeslandesEDuvalMHéronJFGauduchonPPoulainLAcquisition of chemoresistance following discontinuous exposures to cisplatin is associated in ovarian carcinoma cells with progressive alteration of FAK, ERK and p38 activation in response to treatmentGynecol Oncol2006101350751916387351
   PubMed Web of Science ®Google Scholar
• Van NimwegenMJHuigslootMCamierATijdensIBvan de WaterBFocal adhesion kinase and protein kinase B cooperate to suppress doxorubicin-induced apoptosis of breast tumor cellsMol Pharmacol20067041330133916825486
   PubMed Web of Science ®Google Scholar
• KornbergLJAdenovirus-mediated transfer of FRNK augments drug-induced cytotoxicity in cultured SCCHN cellsAnticancer Res2005254349435616309239
   PubMed Web of Science ®Google Scholar
• FangYWangLJinJRef Focal adhesion kinase affects the sensitivity of human hepatocellular carcinoma cell line SMMC-7721 to TNF- α/cycloheximide-induced apoptosis by regulating protein kinase B levelsEur J Biochem20012684513451911502212
   PubMedGoogle Scholar
• WuZMYuanXHJiangPCAntisens oligonucleodes targeting the focal adhesion kinase inhibit proliferation, induce apoptosis and cooperate with cytotoxic drugs in human glioma cellsJ Neurooncol20067711712316314954
   PubMed Web of Science ®Google Scholar
• FangYWangLJinJZhaXFocal adhesion kinase affects the sensitivity of human hepatocellular carcinoma cell line SMMC-7721 to TNF-α/cycloheximide-induced apoptosis by regulating protein kinase B levelsEur J Biochem20012684513451911502212
   PubMedGoogle Scholar
• HalderJKamatAALandenCNJrFocal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapyClin Cancer Res200612164916492416914580
   PubMed Web of Science ®Google Scholar
• SmithCSGolubovskayaVMPeckEEffect of focal adhesion kinase (FAK) downregulation with FAK antisense oligonucleotides and 5-fluorouracil on the viability of melanoma cell linesMelanoma Res200515535736216179862
   PubMed Web of Science ®Google Scholar
• SomloGAtzoriFStraussLDasatinib plus capecitabine (Cap) for progressive advanced breast cancer (ABC): Phase I study CA180004Abstract: 10122009 ASCO Annual MeetingChicago IL, USA
   Google Scholar
• TeohDAyeniTARubattJMIn vitrocharacterization of the antitumor effects of dasatinib (BMS-354825) in combination with paclitaxel and carboplatin in human ovarian cancer cell linesAbstract 828 AACR 2009
   Google Scholar
• SummyJMGallickGETreatment for advanced tumors: SRC reclaims center stageClin Cancer Res20061251398140116533761
   PubMed Web of Science ®Google Scholar
• BiscardiJSBelschesAPParsonsSJCharacterization of human epidermal growth factor receptor and c-Src interactions in human breast tumor cellsMol Carcinog19982142612729585256
   PubMed Web of Science ®Google Scholar
• HitosugiTSasakiKSatoMSuzukiYUmezawaYEpidermal growth factor directs sex-specific steroid signaling through Src activationJ Biol Chem200728214106971070617284441
   PubMed Web of Science ®Google Scholar
• MuthuswamySKSiegelPMDankortDLWebsterMAMullerWJMammary tumors expressing the neu proto-oncogene possess elevated c-Src tyrosine kinase activityMol Cell Biol19941417357437903421
   PubMed Web of Science ®Google Scholar
• Elsches-JablonskiAPBiscardiJSPeavyDRTiceDARomneyDAParsonsSJSrc family kinases and HER2 interactions in human breast cancer cell growth and survivalOncogene200120121465147511313890
   PubMed Web of Science ®Google Scholar
• VadlamudiRKSahinAAAdamLWangRAKumarRHeregulin and HER2 signaling selectively activates c-Src phosphorylation at tyrosine 215FEBS Lett20035431–3768012753909
   PubMed Web of Science ®Google Scholar
• CabiogluNSummyJMillerCCXCL-12/stromal cell-derived factor-1alpha transactivates HER2-neu in breast cancer cells by a novel pathway involving Src kinase activationCancer Res200565156493649716061624
   PubMed Web of Science ®Google Scholar
• IshizawarRCMiyakeTParsonsSJc-Src modulates ErbB2 and ErbB3 heterocomplex formation and functionOncogene200726243503351017173075
   PubMed Web of Science ®Google Scholar
• SongRXZhangZSantenRJEstrogen rapid action via protein complex formation involving ERalpha and SrcTrends Endocrinol Metab200516834735316126407
   PubMed Web of Science ®Google Scholar
• ChuIArnaoutALoiseauSSrc promotes estrogen-dependent estrogen receptor alpha proteolysis in human breast cancerJ Clin Invest200711782205221517627304
   PubMed Web of Science ®Google Scholar
• HuangFReevesKHanXIdentification of candidate molecular markers predicting sensitivity in solid tumors to dasatinib: rationale for patient selectionCancer Res20076752226223817332353
   PubMed Web of Science ®Google Scholar
• FinnRSBengalaCIbrahimNPhase II Trial of Dasatinib in Triple-negative Breast Cancer: Results of Study CA180059SABCS2008
   Google Scholar
• KnowldenJMHutchesonIRJonesHEElevated levels of epidermal growth factor receptor/c-erbB2 heterodimers mediate an autocrine growth regulatory pathway in tamoxifen-resistant MCF-7 cellsEndocrinology200314431032104412586780
   PubMed Web of Science ®Google Scholar
• HiscoxSMorganLBarrowDDutkowskilCWakelingANicholsonRITamoxifen resistance in breast cancer cells is accompanied by an enhanced motile and invasive phenotype: inhibition by gefitinib (‘Iressa’, ZD1839)Clin Exp Metastasis200421320121215387370
   PubMed Web of Science ®Google Scholar
• NicholsonRIHutchesonIRHarperMEModulation of epidermal growth factor receptor in endocrine-resistant, estrogen-receptor-positive breast cancerAnn N Y Acad Sci200296310411512095935
   PubMed Web of Science ®Google Scholar
• MassarwehSOsborneCKJiangSMechanisms of Tumor Regression and Resistance to Estrogen Deprivation and Fulvestrant in a Model of Estrogen Receptor-Positive, HER-2/neu-PositiveBreast Cancer Cancer Res2006661682668273
   Web of Science ®Google Scholar
• ShouJMassarwehSOsborneCKMechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancerJ Natl Cancer Inst2004961292693515199112
   PubMedGoogle Scholar
• HiscoxSJordanNJMorganLGreenTPNicholsonRISrc kinase promotes adhesion-independent activation of FAK and enhances cellular migration in tamoxifen-resistant breast cancer cellsClin Exp Metastasis200724315716717394086
   PubMed Web of Science ®Google Scholar
• Planas-SilvaMDBruggemanRDGrenkoRTStanley SmithJRole of c-Src and focal adhesion kinase in progression and metastasis of estrogen receptor-positive breast cancerBiochem Biophys Res Commun20063411738116412380
   PubMed Web of Science ®Google Scholar
• Planas-SilvaMDHamiltonKNTargeting c-Src kinase enhances tamoxifen’s inhibitory effect on cell growth by modulating expression of cell cycle and survival proteinsCancer Chemother Pharmacol200760453554317186241
   PubMed Web of Science ®Google Scholar
• Planas-SilvaMDWaltzPKEstrogen promotes reversible epithelial-to-mesenchymal-like transition and collective motility in MCF-7 breast cancer cellsJ Steroid Biochem Mol Biol20071041–2112117197171
   PubMed Web of Science ®Google Scholar
• ChenYGuggisbergNJordaMCombined Src and Aromatase Inhibition Impairs Human Breast Cancer Growth In vivo and Bypass Pathways Are Activated in AZD0530-Resistant TumorsClin Cancer Res200915103396340519451593
   PubMed Web of Science ®Google Scholar
• CampbellEJMcDuffETatarovOPhosphorylated c-Src in the nucleus is associated with improved patient outcome in ER-positive breast cancerBr J Cancer200812299111769177419018258
   PubMed Web of Science ®Google Scholar